Remond J A Fijneman

Remond J A Fijneman is Principal Investigator and Associate Group Leader of the Translational Gastrointestinal Oncology group at the Netherlands Cancer Institute, Amsterdam. Research focuses on identification, validation and implementation of biomarkers for colorectal cancer: 1. DNA Structural Variants, using organoid models and tumor tissues. 2. cell-free circulating tumor DNA as prognostic, predictive, and disease monitoring biomarkers, using clinically well-defined patient cohorts.